CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications
暂无分享,去创建一个
[1] A. Dash,et al. CXCL4 and CXCL10 Predict Risk of Fatal Cerebral Malaria , 2011, Disease markers.
[2] C. Hunter,et al. CXCL10 is required to maintain T-cell populations and to control parasite replication during chronic ocular toxoplasmosis. , 2011, Investigative ophthalmology & visual science.
[3] Yong Poovorawan,et al. Expression of TNF-alpha, TGF-beta, IP-10 and IL-10 mRNA in kidneys of hamsters infected with pathogenic Leptospira. , 2010, Comparative immunology, microbiology and infectious diseases.
[4] M. Serio,et al. Comparison between VDR analogs and current immunosuppressive drugs in relation to CXCL10 secretion by human renal tubular cells , 2010, Transplant international : official journal of the European Society for Organ Transplantation.
[5] J. Miyazaki,et al. CXC chemokine ligand 10 DNA vaccination plus Complete Freund's Adjuvant reverses hyperglycemia in non-obese diabetic mice. , 2010, The review of diabetic studies : RDS.
[6] Wei Xu,et al. Integrating individual functional moieties of CXCL10 and CXCL11 into a novel chimeric chemokine leads to synergistic antitumor effects: a strategy for chemokine-based multi-target-directed cancer therapy , 2010, Cancer Immunology, Immunotherapy.
[7] J. Curtis,et al. Increased cytokine response of rhinovirus-infected airway epithelial cells in chronic obstructive pulmonary disease. , 2010, American journal of respiratory and critical care medicine.
[8] M. Diamond,et al. TNF-α-dependent regulation of CXCR3 expression modulates neuronal survival during West Nile virus encephalitis , 2010, Journal of Neuroimmunology.
[9] Ye Xu,et al. CXCL10 expression and prognostic significance in stage II and III colorectal cancer , 2010, Molecular Biology Reports.
[10] K. Kristensson,et al. Identification of stage biomarkers for human African trypanosomiasis. , 2010, The American journal of tropical medicine and hygiene.
[11] J. Shapiro,et al. CXCR3/ligands are significantly involved in the tumorigenesis of basal cell carcinomas. , 2010, The American journal of pathology.
[12] Ziwen Liu,et al. Dipyrithione inhibits IFN-γ-induced JAK/STAT1 signaling pathway activation and IP-10/CXCL10 expression in RAW264.7 cells , 2010, Inflammation Research.
[13] N. Silawat,et al. A preliminary study on pro- and anti-inflammatory cytokine profiles in Plasmodium vivax malaria patients from central zone of India. , 2010, Acta tropica.
[14] F. Fuller,et al. EIAV S2 enhances pro-inflammatory cytokine and chemokine response in infected macrophages. , 2010, Virology.
[15] H. Boddeke,et al. Expression of CXCL10 in cultured cortical neurons , 2010, Journal of neurochemistry.
[16] Tae Woo Kim,et al. Modification of dendritic cells with interferon‐γ‐inducible protein‐10 gene to enhance vaccine potency , 2009, The journal of gene medicine.
[17] E. Fischer,et al. Pneumoviruses infect eosinophils and elicit MyD88-dependent release of chemoattractant cytokines and interleukin-6. , 2009, Blood.
[18] T. Nutman,et al. Patent Filarial Infection Modulates Malaria-Specific Type 1 Cytokine Responses in an IL-10-Dependent Manner in a Filaria/Malaria-Coinfected Population12 , 2009, The Journal of Immunology.
[19] Y. Hsieh,et al. Candidate Genes Associated with Susceptibility for SARS-Coronavirus , 2009, Bulletin of mathematical biology.
[20] Alan Wells,et al. IP-10 induces dissociation of newly formed blood vessels , 2009, Journal of Cell Science.
[21] J. Blackwell,et al. Genetic association between a chemokine gene CXCL-10 (IP-10, interferon gamma inducible protein 10) and susceptibility to tuberculosis , 2009, Clinica Chimica Acta.
[22] H. Pollack,et al. Chemokine IP-10: an adjunct marker for latent tuberculosis infection in children. , 2009, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[23] Honghong Yao,et al. HIV-1 Tat Co-Operates with IFN-γ and TNF-α to Increase CXCL10 in Human Astrocytes , 2009, PloS one.
[24] O. Grip,et al. Atorvastatin Reduces Plasma Levels of Chemokine (CXCL10) in Patients with Crohn's Disease , 2009, PloS one.
[25] M. Norman,et al. IP-10-Mediated T Cell Homing Promotes Cerebral Inflammation over Splenic Immunity to Malaria Infection , 2009, PLoS pathogens.
[26] E. Bateman,et al. Clinical Diagnostic Utility of IP-10 and LAM Antigen Levels for the Diagnosis of Tuberculous Pleural Effusions in a High Burden Setting , 2009, PloS one.
[27] J. Li,et al. CXC‐chemokine‐ligand‐10 gene therapy efficiently inhibits the growth of cervical carcinoma on the basis of its anti‐angiogenic and antiviral activity , 2009, Biotechnology and applied biochemistry.
[28] P. Ravn,et al. IP-10, MCP-1, MCP-2, MCP-3, and IL-1RA hold promise as biomarkers for infection with M. tuberculosis in a whole blood based T-cell assay , 2009, BMC Research Notes.
[29] Yuquan Wei,et al. The anti‐condyloma acuminatum effects of interferon‐inducible protein 10 in vitro , 2009, International journal of dermatology.
[30] F. Kiessling,et al. TNF-α and the IFN-γ-inducible protein 10 (IP-10/CXCL-10) delivered by parvoviral vectors act in synergy to induce antitumor effects in mouse glioblastoma , 2009, Cancer Gene Therapy.
[31] Michael I Hanzly,et al. Antitumor/antiestrogenic effect of the chemokine interferon inducible protein 10 (IP-10) involves suppression of VEGF expression in mammary tissue. , 2009, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[32] G. Mccracken,et al. Tigecycline Therapy Significantly Reduces the Concentrations of Inflammatory Pulmonary Cytokines and Chemokines in a Murine Model of Mycoplasma pneumoniae Pneumonia , 2009, Antimicrobial Agents and Chemotherapy.
[33] V. Bond,et al. Soluble factors from Plasmodium falciparum-infected erythrocytes induce apoptosis in human brain vascular endothelial and neuroglia cells. , 2008, Molecular and biochemical parasitology.
[34] L. Tian,et al. Antitumor efficacy of combination of interferon-gamma-inducible protein 10 gene with gemcitabine, a study in murine model , 2008, Journal of experimental & clinical cancer research : CR.
[35] S. Norley,et al. Accelerated Prion Replication in, but Prolonged Survival Times of, Prion-Infected CXCR3−/− Mice , 2008, Journal of Virology.
[36] A. Rothman,et al. Viral replication and paracrine effects result in distinct, functional responses of dendritic cells following infection with dengue 2 virus , 2008, Journal of leukocyte biology.
[37] S. Ikeda,et al. Candida albicans abrogates the expression of interferon-gamma-inducible protein-10 in human keratinocytes. , 2008, FEMS immunology and medical microbiology.
[38] Ignacio A. Romero,et al. Chemokine production and chemokine receptor expression by human glioma cells: Role of CXCL10 in tumour cell proliferation , 2008, Journal of Neuroimmunology.
[39] A. Rothman,et al. Efficient dengue virus (DENV) infection of human muscle satellite cells upregulates type I interferon response genes and differentially modulates MHC I expression on bystander and DENV-infected cells. , 2008, The Journal of general virology.
[40] S. Kelsen,et al. Human type II pneumocyte chemotactic responses to CXCR3 activation are mediated by splice variant A. , 2008, American journal of physiology. Lung cellular and molecular physiology.
[41] R. Ned,et al. Malaria Journal Plasma Ip-10, Apoptotic and Angiogenic Factors Associated with Fatal Cerebral Malaria in India , 2008 .
[42] T. Tamaya,et al. Expression of Interferon-Gamma-Inducible Protein 10 Related to Angiogenesis in Uterine Endometrial Cancers , 2008, Oncology.
[43] A. Tager,et al. Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria , 2008, Proceedings of the National Academy of Sciences.
[44] Zhijian Yao,et al. Regulatory polymorphisms in the promoter of CXCL10 gene and disease progression in male hepatitis B virus carriers. , 2008, Gastroenterology.
[45] H. Ball,et al. Chemokine Gene Expression during Fatal Murine Cerebral Malaria and Protection Due to CXCR3 Deficiency1 , 2008, The Journal of Immunology.
[46] B. Lu,et al. CXCR3 LIGANDS CONTRIBUTE TO Th1-INDUCED INFLAMMATION BUT NOT TO HOMING OF Th1 CELLS INTO THE LUNG , 2008, Experimental lung research.
[47] Venkatachalam Udhayakumar,et al. Cerebrospinal fluid and serum biomarkers of cerebral malaria mortality in Ghanaian children , 2007, Malaria Journal.
[48] L. Xin,et al. Effects of CXCL10 on Dendritic Cell and CD4+ T-Cell Functions during Leishmania amazonensis Infection , 2007, Infection and Immunity.
[49] S. Coughlan,et al. Elevated serum levels of interferon- gamma -inducible protein-10 in patients coinfected with hepatitis C virus and HIV. , 2007, The Journal of infectious diseases.
[50] H. Keirstead,et al. Therapeutic neutralization of CXCL10 decreases secondary degeneration and functional deficit after spinal cord injury in mice. , 2007, Regenerative medicine.
[51] Kenji Suzuki,et al. Blockade of interferon‐γ‐inducible protein‐10 attenuates chronic experimental colitis by blocking cellular trafficking and protecting intestinal epithelial cells , 2007 .
[52] Kristian Kofoed,et al. CXCL10/IP-10 release is induced by incubation of whole blood from tuberculosis patients with ESAT-6, CFP10 and TB7.7. , 2007, Microbes and infection.
[53] J. Lillard,et al. CXCR3 axis: role in inflammatory bowel disease and its therapeutic implication. , 2007, Endocrine, metabolic & immune disorders drug targets.
[54] Catherine Q Nie,et al. NK Cells Stimulate Recruitment of CXCR3+ T Cells to the Brain during Plasmodium berghei-Mediated Cerebral Malaria1 , 2007, The Journal of Immunology.
[55] J. Shellito,et al. Interleukin-23 (IL-23)-IL-17 Cytokine Axis in Murine Pneumocystis carinii Infection , 2007, Infection and Immunity.
[56] K. Subbarao,et al. The Immunobiology of SARS*. , 2007, Annual review of immunology.
[57] Ming-yuan Li,et al. In vivo administration of plasmid DNA encoding recombinant immunotoxin DT390-IP-10 attenuates experimental autoimmune encephalomyelitis. , 2007, Journal of autoimmunity.
[58] S. Eo,et al. Differential polarization of immune responses by genetic cotransfer of chemokines changes the protective immunity of DNA vaccine against pseudorabies virus , 2007, Immunology.
[59] S. Indraccolo,et al. Anti-angiogenic gene therapy of cancer: current status and future prospects. , 2007, Molecular aspects of medicine.
[60] A. Neumann,et al. IP‐10 predicts viral response and therapeutic outcome in difficult‐to‐treat patients with HCV genotype 1 infection , 2006, Hepatology.
[61] A. White,et al. High Levels of CXCL10 Are Produced by Intestinal Epithelial Cells in AIDS Patients with Active Cryptosporidiosis but Not after Reconstitution of Immunity , 2006, Infection and Immunity.
[62] M. Grimm,et al. Ras-induced modulation of CXCL10 and its receptor splice variant CXCR3-B in MDA-MB-435 and MCF-7 cells: relevance for the development of human breast cancer. , 2006, Cancer research.
[63] L. Soong,et al. CXCL10/Gamma Interferon-Inducible Protein 10-Mediated Protection against Leishmania amazonensis Infection in Mice , 2006, Infection and Immunity.
[64] H. Keirstead,et al. Neutralization of the chemokine CXCL10 reduces apoptosis and increases axon sprouting after spinal cord injury , 2006, Journal of neuroscience research.
[65] S. Kelsen,et al. CXCR3 chemokine receptor-induced chemotaxis in human airway epithelial cells: role of p38 MAPK and PI3K signaling pathways. , 2006, American journal of physiology. Cell physiology.
[66] E. Borden,et al. IFN-α1,8 inhibits tumor-induced angiogenesis in murine angiosarcomas , 2006 .
[67] S. Kelsen,et al. CXCR3 surface expression in human airway epithelial cells: cell cycle dependence and effect on cell proliferation. , 2006, American journal of physiology. Lung cellular and molecular physiology.
[68] N. Bhat,et al. MAP kinase regulation of IP10/CXCL10 chemokine gene expression in microglial cells , 2006, Brain Research.
[69] T. Miyazaki,et al. Antagonist of interferon-inducible protein 10/CXCL10 ameliorates the progression of autoimmune sialadenitis in MRL/lpr mice. , 2006, Arthritis and rheumatism.
[70] R. Bodnar,et al. IP-10 Blocks Vascular Endothelial Growth Factor-Induced Endothelial Cell Motility and Tube Formation via Inhibition of Calpain , 2006, Circulation research.
[71] David Pinson,et al. CXCL10‐induced cell death in neurons: role of calcium dysregulation , 2006, The European journal of neuroscience.
[72] M. Burdick,et al. CXC chemokines in angiogenesis , 2000, Journal of leukocyte biology.
[73] P. Ridker,et al. Anti-Inflammatory Effects of Statins: Clinical Evidence and Basic Mechanisms , 2005, Nature Reviews Drug Discovery.
[74] I. Kurane,et al. Rabies Virus-Induced Activation of Mitogen-Activated Protein Kinase and NF-κB Signaling Pathways Regulates Expression of CXC and CC Chemokine Ligands in Microglia , 2005, Journal of Virology.
[75] T. Darville,et al. Chlamydia trachomatis Induces Expression of IFN-γ-Inducible Protein 10 and IFN-β Independent of TLR2 and TLR4, but Largely Dependent on MyD881 , 2005, The Journal of Immunology.
[76] T. van der Poll,et al. Activation of cytotoxic lymphocytes in patients with scrub typhus. , 2005, The American journal of tropical medicine and hygiene.
[77] H. Doyle,et al. Cytokine and chemokine expression in the central nervous system associated with protective cell-mediated immunity against Cryptococcus neoformans. , 2005, Medical mycology.
[78] T. Saruta,et al. CXC Chemokine Ligand 10 Neutralization Suppresses the Occurrence of Diabetes in Nonobese Diabetic Mice through Enhanced β Cell Proliferation without Affecting Insulitis , 2004, The Journal of Immunology.
[79] S. Inoue,et al. Rabies Virus Stimulates Nitric Oxide Production and CXC Chemokine Ligand 10 Expression in Macrophages through Activation of Extracellular Signal-Regulated Kinases 1 and 2 , 2004, Journal of Virology.
[80] C. Cotman,et al. Neutralization of the chemokine CXCL10 enhances tissue sparing and angiogenesis following spinal cord injury , 2004, Journal of neuroscience research.
[81] Andrew D. Luster,et al. Intracellular Domains of CXCR3 That Mediate CXCL9, CXCL10, and CXCL11 Function* , 2004, Journal of Biological Chemistry.
[82] C. Lam,et al. Severe acute respiratory syndrome: clinical and laboratory manifestations. , 2004, The Clinical biochemist. Reviews.
[83] D. Kolson,et al. Neuronal apoptosis is mediated by CXCL10 overexpression in simian human immunodeficiency virus encephalitis. , 2004, The American journal of pathology.
[84] J. Sung,et al. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome , 2004, Clinical and experimental immunology.
[85] Sergio Romagnani,et al. CXC chemokines: the regulatory link between inflammation and angiogenesis. , 2004, Trends in immunology.
[86] R. Bucelli,et al. Estrogen Disrupts Chemokine-Mediated Chemokine Release from Mammary Cells: Implications for the Interplay between Estrogen and IP-10 in the Regulation of Mammary Tumor Formation , 2004, Breast Cancer Research and Treatment.
[87] H. Weiner,et al. IFN-Inducible Protein 10/CXC Chemokine Ligand 10-Independent Induction of Experimental Autoimmune Encephalomyelitis1 , 2004, The Journal of Immunology.
[88] M. V. von Herrath,et al. Among CXCR3 Chemokines, IFN-γ-Inducible Protein of 10 kDa (CXC Chemokine Ligand (CXCL) 10) but Not Monokine Induced by IFN-γ (CXCL9) Imprints a Pattern for the Subsequent Development of Autoimmune Disease 1 , 2003, The Journal of Immunology.
[89] H. Keirstead,et al. Reducing inflammation decreases secondary degeneration and functional deficit after spinal cord injury , 2003, Experimental Neurology.
[90] N. Hunt,et al. Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria. , 2003, Trends in immunology.
[91] R. Ahmed,et al. Protection from lethal infection is determined by innate immune responses in a mouse model of Ebola virus infection. , 2003, Virology.
[92] G. Ramadori,et al. Expression of the chemokine IP‐10 correlates with the accumulation of hepatic IFN‐γ and IL‐18 mRNA in chronic hepatitis C but not in hepatitis B , 2003, Journal of medical virology.
[93] S. Kojima,et al. Cytokine and chemokine responses in a cerebral malaria-susceptible or -resistant strain of mice to Plasmodium berghei ANKA infection: early chemokine expression in the brain. , 2003, International immunology.
[94] M. Siomos,et al. Regulation of murine cerebral malaria pathogenesis by CD1d-restricted NKT cells and the natural killer complex. , 2003, Immunity.
[95] D. Markovitz,et al. The C-X-C chemokine IP-10 stimulates HIV-1 replication. , 2003, Virology.
[96] D. Seilhean,et al. Perforin-Dependent Brain-Infiltrating Cytotoxic CD8+ T Lymphocytes Mediate Experimental Cerebral Malaria Pathogenesis 1 , 2003, The Journal of Immunology.
[97] T. van der Poll,et al. Reduced interferon-γ release in patients recovered from Legionnaires' disease , 2003, Thorax.
[98] D. Granger,et al. Regulation of Endothelial Cell Adhesion Molecule Expression in an Experimental Model of Cerebral Malaria , 2002, Microcirculation.
[99] L. Rénia,et al. On the Pathogenic Role of Brain-Sequestered αβ CD8+ T Cells in Experimental Cerebral Malaria1 , 2002, The Journal of Immunology.
[100] Semi Kim,et al. Inhibition of endothelial cell survival and angiogenesis by protein kinase A. , 2002, The Journal of clinical investigation.
[101] K. Nagata,et al. The presence of chemokine (MCP-1, MIP-1alpha, MIP-1beta, IP-10, RANTES)-positive cells and chemokine receptor (CCR5, CXCR3)-positive cells in inflamed human gingival tissues. , 2002, Cytokine.
[102] M. D’Elios,et al. Active tuberculosis in Africa is associated with reduced Th1 and increased Th2 activity in vivo , 2002, European journal of immunology.
[103] Lin Chen,et al. Cytokine and chemokine mRNA expression in neutrophils from CBA/NSlc mice infected with Plasmodium berghei ANKA that induces experimental cerebral malaria. , 2001, Parasitology international.
[104] S. Kunkel,et al. EncephalomyelitisDuring Experimental Autoimmune Accumulation in the Central Nervous System T Cell + Control of Encephalitogenic CD4 -Inducible Protein-10) g CXCL10 (IFN-and , 2001 .
[105] B. Chesebro,et al. Differences in Cytokine and Chemokine Responses during Neurological Disease Induced by Polytropic Murine Retroviruses Map to Separate Regions of the Viral Envelope Gene , 2001, Journal of Virology.
[106] R. Garofalo,et al. Inducible Expression of Inflammatory Chemokines in Respiratory Syncytial Virus-Infected Mice: Role of MIP-1α in Lung Pathology , 2001, Journal of Virology.
[107] D. Weiner,et al. DNA Vaccines Encoding Interleukin-8 and RANTES Enhance Antigen-Specific Th1-Type CD4+ T-Cell-Mediated Protective Immunity against Herpes Simplex Virus Type 2 In Vivo , 2000, Journal of Virology.
[108] R. Gillitzer,et al. CXC chemokines Groα/IL‐8 and IP‐10/MIG in Helicobacter pylori gastritis , 2000 .
[109] Sha Quan,et al. CXCR3 Expression and Activation of Eosinophils: Role of IFN-γ-Inducible Protein-10 and Monokine Induced by IFN-γ1 , 2000, The Journal of Immunology.
[110] L. Anderson,et al. Respiratory Syncytial Virus G and/or SH Glycoproteins Modify CC and CXC Chemokine mRNA Expression in the BALB/c Mouse , 2000, Journal of Virology.
[111] D. Rice,et al. Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. , 2000, Environmental health perspectives.
[112] J. Schwartzman,et al. IP-10 is critical for effector T cell trafficking and host survival in Toxoplasma gondii infection. , 2000, Immunity.
[113] S. Frøland,et al. Interferons and interferon (IFN)‐inducible protein 10 during highly active anti‐retroviral therapy (HAART)—possible immunosuppressive role of IFN‐α in HIV infection , 2000, Clinical and experimental immunology.
[114] P. Loetscher,et al. Lymphocyte‐specific chemokine receptor CXCR3: regulation, chemokine binding and gene localization , 1998, European journal of immunology.
[115] C. Mackay,et al. Flexible Programs of Chemokine Receptor Expression on Human Polarized T Helper 1 and 2 Lymphocytes , 1998, The Journal of experimental medicine.
[116] O. Bagasra,et al. The immunobiology of interferon-gamma inducible protein 10 kD (IP-10): a novel, pleiotropic member of the C-X-C chemokine superfamily. , 1997, Cytokine & growth factor reviews.
[117] S. Romagnani,et al. The Th1/Th2 paradigm. , 1997, Immunology today.
[118] L. Koniaris,et al. Interferon-inducible protein-10 identified as a mediator of tumor necrosis in vivo. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[119] Simon A. Jones,et al. Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes , 1996, The Journal of experimental medicine.
[120] D. Taub,et al. Human Interferon-inducible Protein 10 Is a Potent Inhibitor of Angiogenesis in Vivo , 1995 .
[121] J. Ravetch,et al. Biochemical characterization of a gamma interferon-inducible cytokine (IP-10) , 1987, The Journal of experimental medicine.
[122] S. Jhanwar,et al. Interferon-inducible gene maps to a chromosomal band associated with a (4;11) translocation in acute leukemia cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[123] Andrew D. Luster,et al. γ-Interferon transcriptionally regulates an early-response gene containing homology to platelet proteins , 1985, Nature.
[124] P. Méndez-Samperio,et al. Mycobacterium bovis Bacillus Calmette-Guérin (BCG)-induced activation of PI3K/Akt and NF-kB signaling pathways regulates expression of CXCL10 in epithelial cells. , 2009, Cellular immunology.
[125] Kenji Suzuki,et al. Blockade of interferon-gamma-inducible protein-10 attenuates chronic experimental colitis by blocking cellular trafficking and protecting intestinal epithelial cells. , 2007, Pathology international.
[126] E. Borden,et al. IFN-alpha1,8 inhibits tumor-induced angiogenesis in murine angiosarcomas. , 2006, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[127] S. Colla,et al. CXCR3 and its binding chemokines in myeloma cells: expression of isoforms and potential relationships with myeloma cell proliferation and survival. , 2006, Haematologica.
[128] A. Feldman,et al. Interferon γ–Inducible Protein 10 Selectively Inhibits Proliferation and Induces Apoptosis in Endothelial Cells , 2006, Annals of Surgical Oncology.
[129] R. Ransohoff,et al. Chemokine receptor CXCR3: an unexpected enigma. , 2005, Current topics in developmental biology.
[130] T. Darville,et al. Chlamydia trachomatis induces expression of IFN-gamma-inducible protein 10 and IFN-beta independent of TLR2 and TLR4, but largely dependent on MyD88. , 2005, Journal of immunology.
[131] Alberto Mantovani,et al. IFN-γ-inducible protein 10 and pentraxin 3 plasma levels are tools for monitoring inflammation and disease activity in Mycobacterium tuberculosis infection , 2005 .
[132] L. Rénia,et al. On the pathogenic role of brain-sequestered alphabeta CD8+ T cells in experimental cerebral malaria. , 2002, Journal of immunology.
[133] B. Nahlen,et al. Immunity to placental malaria. III. Impairment of interleukin(IL)-12, not IL-18, and interferon-inducible protein-10 responses in the placental intervillous blood of human immunodeficiency virus/malaria-coinfected women. , 2002, The Journal of infectious diseases.
[134] M. Serio,et al. Signal Transduction by the Chemokine Receptor CXCR3 ACTIVATION OF Ras/ERK, Src, AND PHOSPHATIDYLINOSITOL 3-KINASE/Akt CONTROLS CELL MIGRATION AND PROLIFERATION IN HUMAN VASCULAR PERICYTES* , 2001 .
[135] S. Kunkel,et al. CXCL10 (IFN-gamma-inducible protein-10) control of encephalitogenic CD4+ T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis. , 2001, Journal of immunology.
[136] H. Müller-Hermelink,et al. CXC chemokines Gro(alpha)/IL-8 and IP-10/MIG in Helicobacter pylori gastritis. , 2000, Clinical and experimental immunology.
[137] H. Malling,et al. CXCR3 expression and activation of eosinophils: role of IFN-gamma-inducible protein-10 and monokine induced by IFN-gamma. , 2000, Journal of immunology.